Microbial contamination of hematopoietic progenitor cell products: clinical outcome
Authors:
Open Access
- 18 June 2007
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 40 (4) , 365-368
Abstract
We reviewed the results of routine microbiological assays of 3078 infused hematopoietic progenitor cell (HPC) products for autologous and allogeneic transplantation between January 2001 and December 2005. Thirty-seven (1.2%) contaminated products were found. All patients receiving contaminated infusions received empirical antibiotic prophylaxis according to the assay result. None of these patients developed a positive blood culture with the same agent, developed infections that could be attributable to the contaminated product or experienced any clinical sequelae. Coagulase-negative Staphylococcus was found in 32 (86.5%) products. Admission lengths and time to engraftment were within the expected time frame for autologous and allogeneic transplants. Microbial contamination of HPC products occurs at a low frequency; prophylactic use of antibiotics based on the microbiological assay appears to be effective in preventing clinical complications.Keywords
This publication has 11 references indexed in Scilit:
- Safety control of peripheral blood progenitor cell processing—Eight year-survey of microbiological contamination and bag ruptures in a single institutionTransfusion and Apheresis Science, 2005
- Microbial contamination of hematopoietic progenitor cell grafts—incidence, clinical outcome, and cost‐effectiveness: an analysis of 735 graftsTransfusion, 2005
- Bacterial contamination of ex vivo processed PBPC products under clean room conditionsTransfusion, 2003
- Contamination of Bone Marrow Products with an Actinomycete ResemblingMicrobacteriumSpecies and Reinfusion into Autologous Stem Cell and Bone Marrow Transplant RecipientsClinical Infectious Diseases, 2003
- Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapyCytotherapy, 2003
- Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impactCytotherapy, 2003
- Processing of peripheral blood progenitor cell components in improved clean areas does not reduce the rate of microbial contaminationTransfusion, 2002
- Bacterial Contamination of Autologous Bone Marrow: Reinfusion of Culture‐Positive Grafts Does Not Result in Clinical Sequelae during the Posttransplantation CourseVox Sanguinis, 1998
- Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineeringTransfusion, 1996
- Bacterial contamination of peripheral blood progenitor cells for transplantationTransfusion Medicine, 1996